09.25.26 -- What FDA Inspectors Want From Your OOS File

Single-use virus filtration offers key strategic benefits beyond operational convenience, enabling faster time to market, scalable manufacturing, and flexible supply chains for biopharma production.

Fast deployment, scalable production, and rigorous quality control enabled the delivery of over 20 million complex kits in eight months, demonstrating how efficient operations can meet urgent demand.

Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.

Agentic AI links yield optimization, maintenance, and supply chain planning into a unified system that strengthens manufacturing resilience. Explore how these capabilities drive smarter operations.

Accurate cleanroom particle monitoring requires precise isokinetic sampling. Understand how to maintain sampling accuracy and meet regulatory airflow requirements for your facility.

Uncover the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.

See how quality, validation, and IT teams can prepare for the next generation of AI governance in regulated manufacturing. 

Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.

Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

Leverage impeller tip speed and equivalent revolutions as a practical scale-up strategy to ensure consistent, high-quality wet granulation performance across equipment and batch sizes.

Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.

Gain insight into high shear mixers and how they can be used in a variety of ways to create cannabis-infused products.

Classifying eye drops as combination products complicates approval. Delve into how identifying the primary mode of action early and aligning dual quality frameworks prevents costly launch delays.

The transition toward complex biologics and patient-centric delivery is redefining sterile manufacturing. Success now depends on adopting flexible production strategies and advanced technologies.

Faster clinical supply delivery starts with the right strategy. Take a look at how planning, collaboration, communication, and quality systems keep programs on track.

Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.

Automation continues to accelerate progress in life sciences and is preparing today’s PD labs for deeper autonomy. Find out how collaborative innovation can pave the way for smarter operations.